Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 7478622)

Published in Oncogene on November 02, 1995

Authors

A R Clarke1, M C Cummings, D J Harrison

Author Affiliations

1: CRC Laboratories, Department of Pathology, University Medical School, Edinburgh, UK.

Articles citing this

Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A (1997) 3.96

A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev (2001) 2.05

DNA methyltransferases: a novel target for prevention and therapy. Front Oncol (2014) 1.62

Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A (2000) 1.54

Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc Natl Acad Sci U S A (2000) 1.23

Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol (1997) 1.17

PUMA suppresses intestinal tumorigenesis in mice. Cancer Res (2009) 1.16

Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15

Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci U S A (1997) 1.05

Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc Natl Acad Sci U S A (2013) 1.00

The what, where, when and how of Wnt/β-catenin signaling in pancreas development. Organogenesis (2008) 0.98

A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine. BMC Cancer (2008) 0.97

Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology. Front Med (Lausanne) (2015) 0.92

The pleiotropic phenotype of Apc mutations in the mouse: allele specificity and effects of the genetic background. Genetics (2008) 0.87

Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice. Gut (2007) 0.82

Mouse models of intestinal cancer. J Pathol (2015) 0.81

Apc and p53 interaction in DNA damage and genomic instability in hepatocytes. Oncogene (2014) 0.81

Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. Carcinogenesis (2011) 0.80

Mouse models of colorectal cancer as preclinical models. Bioessays (2015) 0.78

Targeting Zfp148 activates p53 and reduces tumor initiation in the gut. Oncotarget (2016) 0.77

Analysis of Axin2 expression and function in murine models for pancreatic cancer. Cell Biosci (2016) 0.75

Articles by these authors

(truncated to the top 100)

Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet (1997) 3.42

Micromachining a miniaturized capillary electrophoresis-based chemical analysis system on a chip. Science (1993) 3.34

Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat Genet (1993) 2.87

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol (2009) 2.65

High-frequency developmental abnormalities in p53-deficient mice. Curr Biol (1995) 2.57

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45

Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol (1991) 1.98

Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol (1999) 1.98

Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene (1994) 1.91

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res (2000) 1.72

p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene (1994) 1.69

Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis (1995) 1.65

Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol (1998) 1.55

Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51

Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol (1995) 1.48

Cellular response to cancer chemopreventive agents: contribution of the antioxidant responsive element to the adaptive response to oxidative and chemical stress. Biochem Soc Symp (1999) 1.41

Transplant histopathology for the general histopathologist. Histopathology (2003) 1.39

Transport, manipulation, and reaction of biological cells on-chip using electrokinetic effects. Anal Chem (1997) 1.32

Circulating anti-neutrophil antibodies in systemic vasculitis. Lancet (1987) 1.30

Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J (1999) 1.26

Prevention of the rapid degradation of subcutaneously implanted Ag/AgCl reference electrodes using polymer coatings. Anal Chem (1994) 1.24

Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax (1994) 1.24

Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene (1999) 1.24

Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett (1996) 1.23

Electrokinetic control of fluid flow in native poly(dimethylsiloxane) capillary electrophoresis devices. Electrophoresis (2000) 1.23

Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer (1996) 1.22

Apoptosis and carcinogenesis. Br J Cancer (1999) 1.21

Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J Biol Chem (1998) 1.20

Depletion of brain norepinephrine in acute hepatic coma. Surgery (1974) 1.14

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol (1997) 1.12

Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol (1995) 1.12

Evaluation of vaginal tampons for collection of specimens for detection of Chlamydial infection. Sex Transm Dis (1997) 1.10

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer (2010) 1.09

Acute renal failure due to interstitial nephritis induced by 'glue-sniffing' with subsequent recovery. Scott Med J (1988) 1.09

Microfluidic devices connected to fused-silica capillaries with minimal dead volume. Anal Chem (1999) 1.08

Evidence that human class Theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes Alpha, Mu and Pi GST in human. Biochem J (1997) 1.08

K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. J Exp Clin Cancer Res (2006) 1.06

Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion. Nucleic Acids Res (2001) 1.04

Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem Biophys Res Commun (1996) 1.04

Microchip-based capillary electrophoresis for immunoassays: analysis of monoclonal antibodies and theophylline. Anal Chem (1997) 1.03

Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol (1995) 1.03

Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Res Treat (1999) 1.03

Colorectal neoplasia in ulcerative colitis-recent advances. Histopathology (2001) 1.02

Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium. Gut (1989) 1.02

Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem (1993) 1.02

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer (1997) 1.02

Integration of immobilized trypsin bead beds for protein digestion within a microfluidic chip incorporating capillary electrophoresis separations and an electrospray mass spectrometry interface. Rapid Commun Mass Spectrom (2000) 0.99

Peripheral T lymphocyte depletion by apoptosis after CD4 ligation in vivo: selective loss of CD44- and 'activating' memory T cells. Clin Exp Immunol (1994) 0.99

Evidence of hydrogen ion secretion from the human gall bladder in vitro. Gut (1992) 0.99

Separation and identification of peptides from gel-isolated membrane proteins using a microfabricated device for combined capillary electrophoresis/nanoelectrospray mass spectrometry. Anal Chem (2000) 0.99

Design of an interface to allow microfluidic electrophoresis chips to drink from the fire hose of the external environment. Electrophoresis (2001) 0.98

Immunoaffinity purification of Schistosoma mansoni soluble egg antigens. J Immunol (1979) 0.98

A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci U S A (1999) 0.98

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women. Breast Cancer Res Treat (2013) 0.98

Membranous glomerulonephritis. J Clin Pathol (1986) 0.98

A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet (1997) 0.97

N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut (1997) 0.97

Glutathione S-transferases in human liver cancer. Gut (1991) 0.96

Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol (1997) 0.96

Variation in the expression of Mu-class glutathione S-transferase isoenzymes from human skeletal muscle. Evidence for the existence of heterodimers. Biochem J (1991) 0.95

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst (1998) 0.95

Pre-donated autologous blood transfusion in scoliosis surgery. J Bone Joint Surg Br (2003) 0.94

Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet (1993) 0.94

p53, mutation frequency and apoptosis in the murine small intestine. Oncogene (1997) 0.94

Characterization of perfluorosulfonic acid polymer coated enzyme electrodes and a miniaturized integrated potentiostat for glucose analysis in whole blood. Anal Chem (1988) 0.94

Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J Pathol (2000) 0.93

Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol (2000) 0.93

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol (2000) 0.93

Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study. Curr Med Res Opin (2012) 0.92

p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett (1998) 0.91

C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology (2007) 0.91

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer (1995) 0.91

Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol (2000) 0.91

The identification of two myoinhibitory peptides, with sequence similarities to the galanins, isolated from the ventral nerve cord of Manduca sexta. Regul Pept (1995) 0.91

Development of a multichannel microfluidic analysis system employing affinity capillary electrophoresis for immunoassay. Anal Chem (2001) 0.91

Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation. J Pathol (2002) 0.91

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer. Br J Cancer (2012) 0.90

Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase. Biochem J (1998) 0.90

A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells. Br J Cancer (2007) 0.90

Preferential over-expression of the class alpha rat Ya2 glutathione S-transferase subunit in livers bearing aflatoxin-induced pre-neoplastic nodules. Comparison of the primary structures of Ya1 and Ya2 with cloned class alpha glutathione S-transferase cDNA sequences. Biochem J (1990) 0.90

Altered DNA repair and dysregulation of p53 in IRF-1 null hepatocytes. FASEB J (1998) 0.90

Integrated self-calibration via electrokinetic solvent proportioning for microfluidic immunoassays. Electrophoresis (2001) 0.90

Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft. FASEB J (1998) 0.90

EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. Eur Respir J (2009) 0.89

mRNA isolation in a microfluidic device for eventual integration of cDNA library construction. Analyst (2000) 0.89

Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis. J Pathol (2000) 0.89

Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology (2000) 0.89

In vitro and in vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing. Anal Chem (1994) 0.89

Construction and evaluation of a capillary array DNA sequencer based on a micromachined sheath-flow cuvette. Electrophoresis (2000) 0.89

Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer (1992) 0.88

Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Res (2002) 0.88

Control strategies for aeroallergens in an animal facility. J Allergy Clin Immunol (1999) 0.88

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. Int J Cancer (1997) 0.88

Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis. J Med Genet (2000) 0.87

p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J (1997) 0.87

Factors influencing capacitance-based monitoring of microbial growth. J Microbiol Methods (1999) 0.87

Microchip systems for immunoassay: an integrated immunoreactor with electrophoretic separation for serum theophylline determination. Clin Chem (1998) 0.87

Evaluation of ofloxacin in the treatment of uncomplicated gonorrhea. Sex Transm Dis (1991) 0.87

Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol (1996) 0.87